Mumbai: SBI Mutual Fund has crossed Rs 20,000-crore mark in assets under 
In early trade, Dabur Pharma was trading up 1.51% to Rs 77.50 after 50 lakh
to Rs 765 in afternoon trades on improved buying ea
After hitting a new historical mark of 15,007.22, the BSE Sensex, finallyEmkay Global Financial Services has reiterated its BUY recommendation on Pine Labs with a target price of Rs225, implying a potential upside of 50% from the current market price of Rs150.
News in Focus
Featured, India Business, Stock Markets, Aadhar Housing Finance, Finance Sector, ICICI Securities, India
ICICI Securities has reiterated its BUY recommendation on Aadhar Housing Finance Ltd with a target price of Rs 625, implying an upside potential of nearly 29 percent from the current market price o
Motilal Oswal Financial Services has reiterated its BUY recommendation on Coforge with a target price of Rs 1,900, implying an upside potential of nearly 30% from the current market price of Rs 1,4
Featured, India Business, Analyst View, Stock Markets, Anand Rathi, India, RateGain Travel Technologies, Retail Sector
RateGain Travel Technologies has emerged as one of the most compelling growth stories within India's travel technology ecosystem, according to Anand Rathi.
Featured, India Business, Analyst View, Cement Sector, Geojit Financial Services, India, Ramco Cements
Rodrygo transfer rumors have lasted because the football logic is stronger than the gossip cycle.
Main Regional Stories
The Indonesia national football team enters 2026 with heavier expectations, even after missing the expanded World Cup.
China's race to close the AI gap with the United States is no longer theoretical — it's a matter of months.
Mumbai-based brokerage Motilal Oswal Financial Services Ltd (MOFSL) has reiterated a BUY rating on Nuvama Wealth Management, setting a one-year price target of Rs 1,860 — implying 23% upside from the stock's current market price of Rs 1,510.
ICICI Securities, through its retail research arm ICICI Direct, has reaffirmed a Buy rating on City Union Bank (CITUNI), pegging a 12-month target price of Rs 240 a share against a current market price of Rs 204 — an implied upside of 18%.
